Activist 13D/13G Filings - Jounce Therapeutics Inc. (JNCE)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company‚Äôs equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, Next
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2024-02-14
08:50 am
Sale
13GJounce Therapeutics, Inc.
JNCE
Deep Track Capital LP0
0%
-4,259,653decrease
(Position Closed)
View
2024-02-09
4:05 pm
Sale
13GJounce Therapeutics, Inc.
JNCE
Opaleye Management Inc.0
0%
-2,810,000decrease
(Position Closed)
View
2024-02-02
12:28 pm
Sale
13GJounce Therapeutics, Inc.
JNCE
Cowen Financial Products LLC0
0%
-3,647,430decrease
(Position Closed)
View
2023-05-05
4:34 pm
Sale
13DJounce Therapeutics, Inc.
JNCE
TANG CAPITAL PARTNERS LP10,000
100%
-5,290,087decrease
(-99.81%)
View
2023-04-12
4:15 pm
Purchase
13GJounce Therapeutics, Inc.
JNCE
Opaleye Management Inc.2,810,000
5.39%
2,810,000increase
(New Position)
View
2023-04-07
4:00 pm
Unchanged
13DJounce Therapeutics, Inc.
JNCE
TANG CAPITAL PARTNERS LP5,300,087
10.2%
0
(Unchanged)
View
2023-03-28
4:00 pm
Unchanged
13DJounce Therapeutics, Inc.
JNCE
TANG CAPITAL PARTNERS LP5,300,087
10.2%
0
(Unchanged)
View
2023-03-17
4:00 pm
Unchanged
13DJounce Therapeutics, Inc.
JNCE
TANG CAPITAL PARTNERS LP5,300,087
10.2%
0
(Unchanged)
View
2023-03-14
5:00 pm
Purchase
13DJounce Therapeutics, Inc.
JNCE
TANG CAPITAL PARTNERS LP5,300,087
10.2%
300,087increase
(+6.00%)
View
2023-03-06
4:00 pm
Purchase
13GJounce Therapeutics, Inc.
JNCE
TANG CAPITAL PARTNERS LP5,000,000
9.7%
5,000,000increase
(New Position)
View
2023-02-14
4:30 pm
Sale
13GJounce Therapeutics, Inc.
JNCE
ORBIMED ADVISORS LLC0
0%
-2,200,200decrease
(Position Closed)
View
2023-02-14
4:06 pm
Sale
13GJounce Therapeutics, Inc.
JNCE
PFM Health Sciences LP345,926
0.7%
-3,626,942decrease
(-91.29%)
View
2023-02-14
4:06 pm
Sale
13GJounce Therapeutics, Inc.
JNCE
Third Rock Ventures II L.P.335,533
0.6%
-3,794,934decrease
(-91.88%)
View
2023-02-14
10:07 am
Purchase
13GJounce Therapeutics, Inc.
JNCE
RTW INVESTMENTS LP5,106,341
9.9%
2,243,143increase
(+78.34%)
View
2023-02-14
08:40 am
Purchase
13GJounce Therapeutics, Inc.
JNCE
Deep Track Capital LP4,259,653
8.24%
259,653increase
(+6.49%)
View
2023-02-14
08:23 am
Purchase
13GJounce Therapeutics, Inc.
JNCE
BANK OF AMERICA CORP
BAC
3,276,699
6.3%
3,276,699increase
(New Position)
View
2023-01-23
3:48 pm
Purchase
13GJounce Therapeutics, Inc.
JNCE
Cowen Financial Products LLC3,647,430
7.05%
567,078increase
(+18.41%)
View
2022-04-22
10:54 am
Purchase
13GJounce Therapeutics, Inc.
JNCE
Cowen Financial Products LLC3,080,352
5.96%
3,080,352increase
(New Position)
View
2022-02-14
4:52 pm
Sale
13GJounce Therapeutics, Inc.
JNCE
Third Rock Ventures II L.P.4,130,467
8.1%
-8,209,361decrease
(-66.53%)
View
2022-02-14
12:37 pm
Purchase
13GJounce Therapeutics, Inc.
JNCE
PFM Health Sciences LP3,972,868
7.8%
1,584,801increase
(+66.36%)
View
Goto 0, 1, Next